These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 12271141)

  • 41. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
    Fingar DC; Salama S; Tsou C; Harlow E; Blenis J
    Genes Dev; 2002 Jun; 16(12):1472-87. PubMed ID: 12080086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.
    Li Y; Inoki K; Guan KL
    Mol Cell Biol; 2004 Sep; 24(18):7965-75. PubMed ID: 15340059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex.
    Murthy V; Han S; Beauchamp RL; Smith N; Haddad LA; Ito N; Ramesh V
    J Biol Chem; 2004 Jan; 279(2):1351-8. PubMed ID: 14559897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A; Tee AR; Taylor PM; Proud CG
    Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
    Beevers CS; Chen L; Liu L; Luo Y; Webster NJ; Huang S
    Cancer Res; 2009 Feb; 69(3):1000-8. PubMed ID: 19176385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress.
    Naegele S; Morley SJ
    J Biol Chem; 2004 Oct; 279(44):46023-34. PubMed ID: 15292274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.
    Hara K; Yonezawa K; Weng QP; Kozlowski MT; Belham C; Avruch J
    J Biol Chem; 1998 Jun; 273(23):14484-94. PubMed ID: 9603962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.
    Khan N; Afaq F; Khusro FH; Mustafa Adhami V; Suh Y; Mukhtar H
    Int J Cancer; 2012 Apr; 130(7):1695-705. PubMed ID: 21618507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway.
    Onda H; Crino PB; Zhang H; Murphey RD; Rastelli L; Gould Rothberg BE; Kwiatkowski DJ
    Mol Cell Neurosci; 2002 Dec; 21(4):561-74. PubMed ID: 12504590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The tuberous sclerosis complex genes in tumor development.
    Mak BC; Yeung RS
    Cancer Invest; 2004; 22(4):588-603. PubMed ID: 15565817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber.
    Jansen FE; Notenboom RG; Nellist M; Goedbloed MA; Halley DJ; de Graan PN; van Nieuwenhuizen O
    Neurology; 2004 Oct; 63(7):1293-5. PubMed ID: 15477556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
    Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
    J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
    Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
    Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.
    Valianou M; Cox AM; Pichette B; Hartley S; Paladhi UR; Astrinidis A
    Cell Cycle; 2015; 14(3):399-407. PubMed ID: 25565629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway.
    Gingras AC; Kennedy SG; O'Leary MA; Sonenberg N; Hay N
    Genes Dev; 1998 Feb; 12(4):502-13. PubMed ID: 9472019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
    Crino PB
    J Child Neurol; 2004 Sep; 19(9):716-25. PubMed ID: 15563019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tuberous sclerosis: from tubers to mTOR.
    Kwiatkowski DJ
    Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rheb fills a GAP between TSC and TOR.
    Manning BD; Cantley LC
    Trends Biochem Sci; 2003 Nov; 28(11):573-6. PubMed ID: 14607085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.
    Zhou Q; Liu C; Liu W; Zhang H; Zhang R; Liu J; Zhang J; Xu C; Liu L; Huang S; Chen L
    Toxicol Sci; 2015 Jan; 143(1):81-96. PubMed ID: 25304210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant beta-catenin signaling in tuberous sclerosis.
    Mak BC; Kenerson HL; Aicher LD; Barnes EA; Yeung RS
    Am J Pathol; 2005 Jul; 167(1):107-16. PubMed ID: 15972957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.